Stalinraja Maruthamuthu, PhD
|
| Title(s) | Postdoctoral Scholar, Surgery |
|---|
| School | School of Medicine |
|---|
| Address | 3333 California Street
San Francisco CA 94118
|
|---|
| Phone | -- |
|---|
| vCard | Download vCard |
|---|
|
|
Biography
| Madurai Kamaraj University, India | PhD | 2016 | Immunogenetics |
| Bhat biotech Ltd, Bangalore, India | Trainee | 2008 | Recombinant Protein characterization |
| Manonmaniam Sundaranar University, Tamil Nadu, India | Master's | 2007 | Biotechnology |
| Madurai Kamaraj University | 2012
-
| 2016 | Meritorious Fellow |
| Madurai Kamaraj University | 2010
-
| 2012 | Genomics Fellow |
| Bhat Biotech Ltd | Jan-
-
| 2008 | DBT Biotech trainee |
| Manonmaniam Sundaranar University | 2005
-
| 2006 | TN- Govt. Students Fellowship |
| Frontiers Cardiovascular Medicine | 2020 | | Reviewer |
| Human immunology | 2018 | | Reviewer |
Overview
I am a post-doctoral Scholar working with Dr.Rajalingam Raja, who is the director of Immunogenetics and Transplantation Laboratory (ITL) at UCSF. During my PhD, I have studied the NK cell receptor diversity in Southern Indian population and revealed the protective role of NK cell receptor KIR in HIV disease progression. Here at UCSF, I am further unravelling the role of KIR and HLA in kidney transplantation outcome. Main theme of my research is to study the influence of host immunogenetic factors against infectious diseases and transplanted organs through molecular and cellular biological approaches.
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Concurrent typing of over 4000 samples by long-range PCR amplicon-based NGS and rSSO revealed the need to verify NGS typing for HLA allelic dropouts. Hum Immunol. 2021 Aug; 82(8):581-587.
Kong D, Lee N, Dela Cruz ID, Dames C, Maruthamuthu S, Golden T, Rajalingam R. PMID: 33980471.
View in:
PubMed Mentions: Fields:
-
Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians. AIDS. 2018 11 28; 32(18):2679-2688.
Maruthamuthu S, Rajalingam R, Pandian K, Madasamy S, Manoharan M, Pitchai L, Murugesan A, Mariakuttikan J. PMID: 30289808.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
P124 Centromeric BB KIR genotypes that are lacking KIR2DL3 are associated with HIV seropositive individuals of long term non progressor to AIDS. 2017; 78:1.
Stalinraja, Maruthamuthu; Suresh, Madasamy; Mythreyee, Manoharan; Rajalingam, Raja; Jayalakshmi, Mariakuttikan; . View Publication.
-
Predominance of B haplotype associated KIR genes in Tamil Speaking Dravidians. Hum Immunol. 2015 May; 76(5):344-7.
Maruthamuthu S, Mariakuttikan J. PMID: 25842054.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCells
-
Protective role of Mannose binding Lectin (MBL2) promoter haplotypes on TB infection in South Indian HIV-1 patients. 2014; 14(3):1.
Pandian, K., Maruthamuthu, S., Madasamy, S., Mariakuttikan, J . View Publication.
-
Homozygous KIR2DL3 confers susceptibility to tuberculosis infection in HIV seropositive individuals. 2014; 14(3):1.
Maruthamuthu, Stalinraja; Madasamy, Suresh; Mariakuttikan, Jayalakshmi; . View Publication.
-
Protective effect of KIR3DS1 in asymptomatic HIV-1 seroconverters towards AIDS. 2012; 12(1):1.
Stalinraja, M; Kalyanaraman, N; Leishman, P; Suresh, M; Jayalakshmi, M; . View Publication.
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs